Helicobacter pylorisecond-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
出版年份 2015 全文链接
标题
Helicobacter pylorisecond-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 41, Issue 8, Pages 768-775
出版商
Wiley
发表日期
2015-02-23
DOI
10.1111/apt.13128
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia
- (2016) Cemal Nuri ERCIN et al. Turkish Journal of Gastroenterology
- Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
- (2013) Xiao Liang et al. Clinical Gastroenterology and Hepatology
- Effect of Fluoroquinolone Resistance on 14-day Levofloxacin Triple and Triple Plus Bismuth Quadruple Therapy
- (2013) Jingxian Liao et al. HELICOBACTER
- Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple “sequential” or “concomitant” treatment to eradicateH. pyloriinfection
- (2013) Javier P. Gisbert et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
- (2012) A. G. McNicholl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection
- (2012) Alessandro Federico et al. GASTROENTEROLOGY
- Which Therapy for Helicobacter pylori Infection?
- (2012) David Y. Graham et al. GASTROENTEROLOGY
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate
- (2012) Marco Manfredi et al. HELICOBACTER
- The Efficacy of Second-Line Anti-Helicobacter pyloriTherapy Using an Extended 14-Day Levofloxacin/Amoxicillin/Proton-Pump Inhibitor Treatment - A Pilot Study
- (2012) Seng-Kee Chuah et al. HELICOBACTER
- Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
- (2012) Javier P. Gisbert et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Quadruple therapy with moxifloxacin and bismuth for first-line treatment ofHelicobacter pylori
- (2012) Antonio Francesco Ciccaglione WORLD JOURNAL OF GASTROENTEROLOGY
- The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
- (2012) Francis Mégraud Therapeutic Advances in Gastroenterology
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough
- (2011) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days
- (2011) Maria Pina Dore et al. HELICOBACTER
- Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice
- (2010) Stefano Pontone et al. DIGESTIVE AND LIVER DISEASE
- Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection
- (2010) Takahisa Furuta et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
- (2010) M. Romano et al. GUT
- The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China
- (2010) Wen Gao et al. HELICOBACTER
- Bismuth improves PPI-based triple therapy for H. pylori eradication
- (2010) Peter Malfertheiner Nature Reviews Gastroenterology & Hepatology
- Helicobacter pyloriInfection
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
- (2010) Yuqin Li et al. WIENER KLINISCHE WOCHENSCHRIFT
- Standard triple, bismuth pectin quadruple and sequential therapies forHelicobacter pylorieradication
- (2010) Xiao-Zhong Gao WORLD JOURNAL OF GASTROENTEROLOGY
- Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
- (2008) S. Di Caro et al. DIGESTIVE AND LIVER DISEASE
- Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures
- (2008) P. I. Hsu et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- ¿Son más eficaces dosis más elevadas de inhibidores de la bomba de protones para el tratamiento de la infección por Helicobacter pylori?
- (2008) Albert Villoria Gastroenterologia y Hepatologia
- Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
- (2008) Alexander C Ford et al. WORLD JOURNAL OF GASTROENTEROLOGY
- “Rescue” regimens after Helicobacter pylori treatment failure
- (2008) Javier P Gisbert WORLD JOURNAL OF GASTROENTEROLOGY
- Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
- (2007) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started